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Abstract
PeptidoGlycan Recognition Proteins (PGRPs) are key regulators of the insect innate antibacterial response. Even if they have
been intensively studied, some of them have yet unknown functions. Here, we present a functional analysis of PGRP-LA, an
as yet uncharacterized Drosophila PGRP. The PGRP-LA gene is located in cluster with PGRP-LC and PGRP-LF, which encode a
receptor and a negative regulator of the Imd pathway, respectively. Structure predictions indicate that PGRP-LA would not
bind to peptidoglycan, pointing to a regulatory role of this PGRP. PGRP-LA expression was enriched in barrier epithelia, but
low in the fat body. Use of a newly generated PGRP-LA deficient mutant indicates that PGRP-LA is not required for the
production of antimicrobial peptides by the fat body in response to a systemic infection. Focusing on the respiratory tract,
where PGRP-LA is strongly expressed, we conducted a genome-wide microarray analysis of the tracheal immune response of
wild-type, Relish, and PGRP-LA mutant larvae. Comparing our data to previous microarray studies, we report that a majority
of genes regulated in the trachea upon infection differ from those induced in the gut or the fat body. Importantly,
antimicrobial peptide gene expression was reduced in the tracheae of larvae and in the adult gut of PGRP-LA-deficient
Drosophila upon oral bacterial infection. Together, our results suggest that PGRP-LA positively regulates the Imd pathway in
barrier epithelia.
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Introduction
Drosophila, in contrast to mammals, lacks adaptive immunity and
therefore relies entirely on innate immunity for defense against
invading pathogens [1,2]. Microorganisms are recognized through
the interaction between microbial compounds and host pattern-
recognition receptors. In insects, the peptidoglycan recognition
proteins (PGRPs) are a major class of pattern-recognition
receptors that sense bacteria by interacting with peptidoglycan
and regulate host antibacterial defenses. In Drosophila, the Toll and
Imd pathways are the two major signaling cascades regulating the
massive expression of antimicrobial peptide genes and other
immune genes by the fat body following a systemic infection [3–5].
The Toll pathway is strongly induced by Gram-positive bacteria
and fungi, and controls the expression of several genes, notably the
antifungal peptide gene Drosomycin; the Imd pathway is strongly
induced by Gram-negative and bacillus-shaped Gram-positive
bacteria and regulates the expression of genes such as Diptericin,
encoding an antibacterial peptide [6]. Activation of both pathways
by bacteria is achieved through the sensing of specific forms of
peptidoglycan by PGRPs. Peptidoglycan is an essential cell wall
component of bacteria, composed of long glycan chains with
alternating N-acetylglucosamine and N-acetylmuramic acid resi-
dues that are cross-linked to each other by short peptide bridges.
The third residue of these stem peptides differs between bacteria: it
is a lysine in Gram-positive cocci and a meso-diaminopimelic acid
(DAP) in both Gram-negative bacteria and Gram-positive bacilli,
such as Bacillus and Listeria species [7]. Studies using highly purified
bacterial compounds have shown that the highest Toll pathway
activity is observed upon injection of Lysine-type peptidoglycan,
while the Imd pathway is activated by DAP-type peptidoglycan
[8]. Further studies have shown that both polymeric and
monomeric DAP-type peptidoglycan can activate the Imd
pathway. A specific monomer, the GlcNAc-MurNAc(anhydro)-
L-Ala-c-D-Glu-meso-DAP-D-Ala, also known as tracheal cytotoxin
(TCT), has been identified as the minimal peptidoglycan motif
capable of efficient induction of the Imd pathway [9,10].
PGRPs form a conserved family of proteins sharing a 160 amino
acid domain (the PGRP domain) with similarities to bacteriophage
T7 lysozyme, a zinc-dependent N-acetylmuramoyl-L-alanine
amidase that removes peptides from the glycan chains of
peptidoglycan [11,12]. The Drosophila genome encodes 13 PGRPs,
some of which retain amidase properties. The PGRPs of this
subgroup, referred to as catalytic PGRPs, have demonstrated
(PGRP-SC1A/B, LB, SB1) or predicted (PGRP-SB2, SC2) zinc-
dependent amidase activity, which reduces or eliminates the ability
of peptidoglycan to elicit an immune response [13–15]. PGRP-LB
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and to a lesser extent PGRP-SC1A/SC1B/SC2 have been shown
to down-regulate the Imd pathway activity by scavenging
peptidoglycan [16–18]. The exact function of PGRP-SB1/SB2 is
not yet clear: it was proposed that this secreted PGRP could
function as an antibacterial protein [15], but a recent genetic
analysis did not identify any immune phenotype [19]. The non-
catalytic PGRPs (PGRP-SA, SD, LA, LC, LD, LE, LF) lack the
zinc-binding residues required for amidase activity but some of
them retain the ability to bind peptidoglycan and function as
bacteria sensors. PGRP-SA and PGRP-SD are secreted proteins
circulating in the hemolymph that have been shown to activate the
Toll pathway in response to the Lysine-type peptidoglycan found
in most Gram-positive bacteria [20,21]. The receptor PGRP-LC,
located at the plasma membrane, induces the Imd pathway when
activated by DAP-type peptidoglycan [22–24]. PGRP-LE is
produced in both extracellular and intracellular forms and has
been shown to participate in the sensing of bacteria containing
DAP-type peptidoglycan in two different manners. A secreted
fragment of PGRP-LE corresponding to the PGRP domain alone
enhances PGRP-LC-mediated peptidoglycan recognition on the
cell surface [25]. In contrast, the full-length form of PGRP-LE is
cytoplasmic and acts as an intracellular receptor for monomeric
peptidoglycan, effectively bypassing the requirement for PGRP-
LC [26]. While PGRP-LC is the main receptor upstream of the
Imd pathway in the fat body, both PGRP-LC and PGRP-LE
account for the sensing of Gram-negative bacteria upstream of the
Imd pathway in the gut [27,28]. A gene in cluster with PGRP-LC,
PGRP-LF encodes a transmembrane protein with two PGRP
domains. Studies have indicated that PGRP-LF does not bind
peptidoglycan but inhibits the activation of PGRP-LC by
competing with PGRP-LC dimerization [29,30]. The functions
of PGRP-LD and PGRP-LA are not yet known.
In this study, we report a functional analysis of PGRP-LA, a
non-catalytic PGRP encoded by a gene of the PGRP-LC genomic
cluster. PGRP-LA expression is enriched in several barrier epithelia
such as the hindgut and tracheae whereas its expression in the fat
body is low [31]. Based on over-expression, deletion and rescue
experiments, this work suggests that PGRP-LA has a regulatory role
and is involved in the fine-tuning of the Imd pathway in barrier
epithelia. Our study also includes a genome-wide analysis of gene
expression in tracheae in the presence or absence of PGRP-LA and
Relish. Comparing this analysis with previous studies monitoring
the fat body and gut responses to bacterial infection reveals a high
tissue-specificity of the pool of genes regulated upon infection.
Results
Structure predictions indicate that PGRP-LA would not
bind to peptidoglycan
PGRP-LA is located at the 59 boundary of a cluster of three
genes that includes PGRP-LC and PGRP-LF. It encodes three
isoforms, which are referred to here as PGRP-LAD, LAF and LAC
(Figure 1A), following Flybase nomenclature, but which were
previously referred to as PGRP-LAa, LAb and LAc respectively
[32]. Sequence analysis predicted that the isoforms encoded by
PGRP-LA differ considerably in their protein domain organiza-
tions. PGRP-LAD encodes a putative transmembrane protein with
an intracellular domain containing a RIP Homotypic Interaction
Motif (RHIM) [26,33], but lacking the PGRP domain. The
RHIM domain is also found in PGRP-LC and PGRP-LE and has
been shown to be necessary in these receptors for induction of the
Imd pathway [26]. PGRP-LAF contains both a putative
transmembrane domain and a PGRP domain, a structure similar
to that of the PGRP-LC receptor, except its lack of a RHIM
domain. PGRP-LAC encodes a short protein of 138 amino acids
composed exclusively of a N-terminus-truncated PGRP domain:
although the typical PGRP domain structure comprises a central
b-sheet composed of six b-strands surrounded by three a-helices,
PGRP-LAC lacks the b1 and b2 sheets and a part of the a1 helix
(see Figure 1B).
The PGRP domain of most PGRPs has been shown to interact
with peptidoglycan. Nevertheless, biochemical studies have shown
that some PGRPs, namely PGRP-LF and PGRP-LCa, have lost
the capacity to bind peptidoglycan and function as a negative
regulator and co-receptor of PGRP-LCx, respectively [30,34]. To
get an insight on PGRP-LA function, we analyzed the sequence of
its PGRP domain and its conservation among species. PGRP-LA is
found in several insect species and its sequence is well conserved
across species; the Drosophila PGRP-LA domain shares 60%
identity with Aedes and Culex and 52% with Anopheles (Figure 1B).
In addition, the PGRP-LA domain sequence shares only 35%
identity with PGRP-LE (60/168), 32% with PGRP-LCx (46/142),
and 31% with PGRP-LF (52/164). These percentages are lower
than the identity rate among other PGRPs (e.g. PGRP-LCx shares
40 to 52% with PGRP-LF, SD, SC1 and SA), but are above the
30% threshold necessary to predict that the folding of PGRP-LA is
similar to the folding of other PGRPs [35]. Study of the putative
peptidoglycan binding site of PGRP-LA using both the 3D model
obtained with the Phyre software [36] and the sequence alignment
with PGRP-LCx leads to three main observations. First, among
the 10 residues of PGRP-LCx implicated in the binding to TCT
[37], only two are conserved in PGRP-LA (Figure 1B), although
these residues are highly conserved in PGRPs [14,38]. In
particular, His388, which binds to GlcNAc, is replaced by an
alanine, Tyr399, which is located in the central part of the binding
crevice, is replaced by a serine, and Trp394, which stacks against
the elongated side chain of DAP, is replaced by a leucine. In
addition several residues, which are not directly in contact with
TCT, but are engaged in shaping the binding crevice, are also not
conserved in PGRP-LA. This is the case for Thr366, which is
replaced by an isoleucine. Second, the PGRP domain of PGRP-
LA displays a deletion of four amino acids in the b4–b5 loop
(Figure 1B), which is known to be crucial for the binding to
peptidoglycan, as an insertion of two residues in this loop prevents
the binding to peptidoglycan in PGRP-LCa [34]. Third, an
insertion of two residues occurs in the b2-a1 loop (Figure 1B),
which has been shown to stabilize the pyranose ring of the
MurNAc sugar of TCT. Considering these three points, it seems
very unlikely that PGRP-LA binds peptidoglycan, suggesting that
this PGRP is not a receptor but could have a regulatory role.
PGRP-LA is expressed in barrier epithelia and is up-
regulated in response to infection
PGRP-LA was shown to be expressed at a moderate level during
most developmental stages and its level of expression is higher in
late larvae and prepupae [32,39]. We confirmed these results by
RT-qPCR analysis (Figure S1A). Data from FlyAtlas reveal a
strong expression of PGRP-LA in barrier epithelia, especially in
salivary glands and tracheae of larvae and in the hindgut and eyes
of adults, while it was weakly expressed in the fat body (9% and
21% of the average expression respectively for larvae and adults,
Figure 2A) [31]. RT-qPCR with PGRP-LAD or PGRP-LAC/F
specific primers shows a similar distribution of these isoforms in all
the tissues tested except in Malpighian tubules where PGRP-LAC
and F were absent (Figure S1A). Previous studies have shown that
PGRP-LA expression is induced about two-fold in adults upon
septic injury [3,30]. Upon oral infection with Ecc15, PGRP-LA was
also shown to be induced 1.6-fold and 10-fold in adult gut and
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larval tracheae, respectively [40,41]. Using RT-qPCR, we
confirmed that PGRP-LA expression is induced in whole flies after
septic injury and in the midgut after oral infection with the Gram-
negative bacterium Erwinia carotovora carotovora 15 (Ecc15)
(Figures 2B, S1B). Together, these data indicate that PGRP-LA
is induced after epithelial and septic infection.
Over-expression of PGRP-LAD induces the Imd pathway
Over-expression of PGRP-LE and PGRP-LC is sufficient to
activate the Imd pathway, in agreement with their function
upstream of this signaling cascade [22,42]. This prompted us to
investigate the effect of the over-expression of PGRP-LA isoforms
on the Imd pathway activation. Figure 3A shows that, using the
da-Gal4 driver, over-expression in unchallenged flies of PGRP-
LAD but not that of PGRP-LAF or PGRP-LAC was sufficient to
induce a very high expression level of Diptericin, an antibacterial
peptide gene used as a read-out of the Imd pathway. Diptericin
induction by PGRP-LAD required Dredd and Tak1, but not
PGRP-LC (Figure 3B). We also observed that ubiquitous over-
expression of PGRP-LAD with the da-Gal4 driver induces some
lethality, as observed upon PGRP-LC ubiquitous over-expression
(data not shown). The observation that PGRP-LAD can activate
the Imd pathway, the presence of a RHIM domain, and the
location of PGRP-LA in the same cluster as PGRP-LC and LF are
Figure 1. Description of PGRP-LA genomic locus and isoforms. A. Scheme of the locus containing PGRP-LA, PGRP-LC and PGRP-LF. Each gene
contains at least one PGRP domain (orange) and PGRP-LA and LC contain a transmembrane domain (TM, green) and a RHIM motif (blue). No signal
peptide has been predicted in the PGRP-LA sequence, and the C-terminal sequence (purple) contains 2 Cys residues. PGRP-LA encodes three isoforms,
depicted under the gene: boxes represent the exons, of which the coding sequence is colored in red. PGRP-LA2A (LA2A) deletion was performed by
imprecise excision of the P-element G14937 (KAIST library) and PGRP-[LA,LC]D (LALCD) by FRT mediated deletion of the region between the P-
elements 1930 and 4396. PGRP-LCE12 (LCE12) deletion has already been published [22]. In PGRP-LAC, the hatched box represents a sequence between a
start and a stop codon, but which is not predicted to be the coding sequence (Flybase). Fp, Rg: localization of the primers used for RT-qPCR. B.
Alignment of the proteic sequences of the PGRP domains of PGRP-LA in Drosophila (Dm), Anopheles gambiae (Ag) and Culex quinquefasciatus (Cq) and
of Drosophila PGRP-LCx, of which the crystal structure has already been solved. Blue boxes contain conserved amino acids (identities and similarities
are highlighted and written in red respectively). The residues that are directly in contact with TCT in the structure of the complex with PGRP-LCx [37]
are marked with yellow triangles. The numbering corresponds to PGRP-LCx. The two residues insertion in the b2-a1 loop and the four residues
deletion in the b4–b5 loop are denoted with green and red stars, respectively.
doi:10.1371/journal.pone.0069742.g001
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suggestive of a role of PGRP-LA in the regulation of the Imd
pathway.
PGRP-LA is dispensable for the induction of a systemic
immune response
In order to investigate the role of PGRP-LA in vivo, we generated
a Drosophila strain deficient for PGRP-LA by imprecise excision of
the P-element G14937 (from the Korea Advanced Institute of
Science and Technology library). PGRP-LA2A mutant bears a
deletion of 1401 bp upstream of the P-element insertion site,
uncovering the PGRP domain sequence. This deletion includes
the exons encoding the whole of the PGRP-LAC and LAF isoforms
and the last four exons of the PGRP-LAD isoform (Figure 1A). In
agreement with the molecular characterization, we found that
PGRP-LA2A adults did not express PGRP-LA mRNA (see below). In
addition, PGRP-LA2A mutants were viable and fertile and did not
show any apparent developmental defects as observed for all the
other PGRP deficient lines described so far. We introgressed the
PGRP-LA2A mutation into the wild-type CantonS background by
backcrossing PGRP-LA2A males with CantonS females for three
generations in order to reduce possible effects of the genetic
background.
As PGRP-LA expression is induced upon infection and as its
over-expression up-regulates antibacterial gene transcription, we
hypothesized that this gene was involved in the immune response.
In order to clarify its role, we analyzed the effect of PGRP-LA
deletion on the systemic immune response to different classes of
microorganisms injected into the body cavity. Inactivation of
PGRP-LA did not impact fly survival to injection with Gram-
negative bacteria (Ecc15, Salmonella typhimurium), Gram-positive
bacteria (L. monocytogenes, Enterococcus faecalis), or fungi (Aspergillus
glaucus), whereas inhibition of the Imd pathway in a Relish mutant
or the Toll pathway in a Spa¨tzle mutant had a dramatic effect upon
survival (Figure 4A, B and Figure S2 A–C). Consistent with
these survival analyses, we did not detect an effect of PGRP-LA2A
mutation on the expression levels of Diptericin after systemic
Figure 2. Analysis of PGRP-LA expression. A. Microarray tissue-specific expression of PGRP-LA, data from Flyatlas [31]. Expression is shown as a
ratio of PGRP-LA mRNA enrichment in each tissue to the average of PGRP-LA mRNA enrichment in all the tissues. All 3 isoforms are detected by the
PGRP-LA probes. Thoracicoabd gg – thoracicoabdominal ganglion, V. and M. spermatheca – virgin and mated spermatheca. B. RT-qPCR analysis of
PGRP-LA expression in whole adults subjected to a septic injury with Erwinia carotovora carotovora 15 (Ecc15). UC – Unchallenged. Data are the mean
of 7 repeats, indicated as fold change of UC, and error bars show standard error. Data were analyzed by ANOVA1 followed by Dunnett’s multiple
comparison test using UC as reference (UC vs 24 h are not significantly different).
doi:10.1371/journal.pone.0069742.g002
Figure 3. PGRP-LAD over-expression leads to induction of the
Imd pathway. A. Measurement of Diptericin (Dpt) by RT-qPCR in
whole males over-expressing each isoform of PGRP-LA under the
control of the ubiquitous da-Gal4 driver, using UAS-PGRP-LAC (LAC), UAS-
PGRP-LAD (LAD) and UAS-PGRPLAF (LAF) transgenes. B. Measurement of
Dpt by RT-qPCR in PGRP-LC, Dredd, or Tak1-deficient whole males over-
expressing PGRP-LAD under the control of the ubiquitous da-Gal4 driver.
Results are shown as fold change of Dpt expression versus wild-type (+)
unchallenged controls. Data are expressed as a percentage of Dpt/
RpL32 6 h after septic injury (SI) and are the mean of three experiments;
error bars indicate standard errors. In A, B, data were analyzed by
ANOVA1 followed by Dunnett’s multiple comparison test using wt (i.e.
da-Gal4 x w) (A) and wt (SI) (B) as references (a and b groups are
statistically different, p,0.01 (A) and p,0.05 (B)).
doi:10.1371/journal.pone.0069742.g003
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infection with Ecc15 in larvae and adults, infection with L.
monocytogenes or injection of DAP-type peptidoglycan or TCT in
adults, nor on levels of Drosomycin (a read-out of the Toll pathway)
after systemic infection with the Gram-positive bacterium Micro-
coccus luteus in adults (Figure 4C–E and Figure S2 D, E). These
data indicate that PGRP-LA does not function as an essential
recognition receptor in either the Toll or the Imd pathway during
the systemic immune response of adults. Given that PGRP-LA
expression is enriched in epithelia, we hypothesized that this
PGRP might be involved in peptidoglycan translocation and long-
range activation of the systemic response observed upon oral
bacterial infection in PGRP-LB deficient flies or upon genital
infection [43,44]. However, we did not find any role of PGRP-LA
in the activation of the systemic response upon gut infections with
Ecc15 or P. entomophila, or genital infections with Ecc15 (Figure 4F–
H).
Finally, we generated a PGRP-LA, PGRP-LC double mutant in
order to test if any involvement of PGRP-LA in the systemic
response was masked due to a redundancy between PGRP-LA and
PGRP-LC, as reported for PGRP-LE [25]. This mutant, referred
to as PGRP-[LA,LC]D, was produced by flp-frt excision of a 15 kb
region encompassing both genes, as depicted in Figure 1A. No
difference in the susceptibility to infection or in the immune
response activation was observed between PGRP-[LA,LC]D and
PGRP-LCE12, a deletion containing only the PGRP-LC gene [22]
(Figures 4A, C, F and S2A, C). We conclude that PGRP-LA
does not play a major role in the systemic immune response.
A microarray analysis reveals a role of PGRP-LA in
antimicrobial genes expression in tracheae
In the absence of any overt immune function for PGRP-LA in
the fat body, we next explored its role in the tracheae of larvae, a
tissue in which PGRP-LA expression is enriched (Figure 2A) and
up-regulated in response to infection [41]. Since the tracheal
immune response is poorly characterized, we first used an
unbiased approach and performed a genome-wide microarray
analysis to compare the list of genes induced in the tracheae upon
infection and monitor the effect of the PGRP-LA2A mutation.
To determine the genes specifically induced in tracheae, we
investigated transcriptome variations in dissected tracheae of
larvae infected with the Gram-negative bacterium Ecc15. We
chose Ecc15 as this bacterial strain strongly induces the Imd
pathway in the tracheae upon bacterial infection, as revealed by
the induction of the Drosomycin gene (which can be used as a read-
out of Imd pathway in the trachea, see [41,45]). The transcrip-
tomes of wild-type, RelishE20 and PGRP-LA2A third-instar larvae
were analyzed in unchallenged conditions and 24h after placing
larvae in Ecc15-contaminated fly medium at 18uC (see Materials
and Methods and [46]), using Affymetrix GeneChip Drosophila
Genome 2.0 Array. Our analysis identified 898 genes whose
expression significantly varied in response to Ecc15 infection in the
wild-type strain. We focused our attention on the genes that differ
by at least a 2-fold change over unchallenged condition,
corresponding to 119 induced and 105 repressed transcripts,
30% of which vary by more than 4-fold (Figure 5A; see
Figure 5B for a selection of up-regulated genes and Table S1
for complete data set of regulated genes). Using a global
classification, more than half of the tracheae-regulated genes were
assigned to six functional categories: immunity, stress response,
signaling, proteases and inhibitors, metabolism and transport, and
chitin/cuticle metabolism (Figure 5C). Moreover, our analysis
revealed a large set of previously unidentified bacteria-responsive
genes, which are specific to the tracheae (71/119 and 96/105 in
up and down-regulated genes respectively, Figure 5B and Table
S1). To determine the contribution of the Imd pathway to
antimicrobial defense in the tracheae, we examined the effect of
the Relish mutation on gene expression. The expression of 54 up-
regulated genes and 20 down-regulated genes was altered at least
2-fold in a Relish background compared to wild-type, with clear
enrichment of Relish target genes among the most strongly
induced genes (Figure 5A and Table S1). We found that 79%
(19/24) of the genes annotated as immune genes were affected in
the tracheae of Relish mutant flies (Table S1). Of these immune
genes 71% (17/24) have been previously reported to be induced in
the systemic or gut immune responses in adults [40,47]. These
genes may represent the ‘‘core’’ of Imd pathway-regulated genes
and include PGRP-SD, SB1 and LF, most antibacterial peptide
genes, genes coding for Imd pathway components (Pirk, Relish,
PGRP-LB), as well as TepII and Transferrin 1.
The tracheal response to bacteria appears quantitatively less
complex than the response occurring in the gut: 224 genes were
modulated in the trachea using a two-fold criteria compared to
900 genes in the gut [40]. Although we cannot completely rule out
an effect of the differences in stages or experimental protocols, we
tend to attribute this difference to the fact that the gut response to
bacteria also comprises an epithelium renewal response through
stem cell proliferation and differentiation (Figure 5B) [40]. In the
tracheae, infection induced a new set of genes notably involved in
the stress response and oxidoreduction. Prominent among the
repressed genes is a large set of chitin binding proteins, especially
the Twdl family, of which 7 members are down-regulated in the
tracheae, suggesting a remodeling of the highly structured intima,
thin chitinous cuticle covering the tracheae [48], in response to
infection. Thus, infection with Ecc15 alters the physiology of larval
tracheae, with a repression of chitin metabolism and the
stimulation of immune and stress responses, as well as changes
in signaling and metabolism.
We then investigated the impact of PGRP-LA2A deletion on the
transcriptome of tracheae. We confirmed that the expression of
PGRP-LA was lost in the mutant (Figure 6A) and that the
expression of PGRP-LC, which is located just upstream of the 39
end of PGRP-LA, was not impaired (fold change LA2A/Cs: 1.4 both
in unchallenged and infected conditions). We observed that 143
genes were more than 2-fold up- or down-regulated in PGRP-LA2A
as compared to wild-type (45 of them, whose expression varies
more than 3-fold threshold in the mutant, are shown in
Figure 6A). The most significant difference between wild-type
and PGRP-LA2A was the lower expression of many targets of the
Imd pathway, notably antibacterial peptide genes, in both
unchallenged and challenged conditions. For instance, expression
of Defensin, Drosomycin and Drosocin were respectively 34, 14 and 13-
fold lower in unchallenged PGRP-LA2A compared to wild-type
larvae (Figure 6A). Antimicrobial peptide genes were induced in
PGRP-LA2A tracheae in response to Ecc15, but reached a lower
level than in wild-type tracheae. RT-qPCR using independent
unchallenged tracheal samples confirmed that Defensin and
Drosomycin transcripts were significantly lower in PGRP-LA2A
compared to wild-type (Figure 6B).
PGRP-LA participates in the activation of the Imd
pathway in several barrier epithelia
The result above suggests a role of PGRP-LA in antimicrobial
peptide gene expression in the tracheae, but not in the fat body.
Nevertheless, the antimicrobial genes remain largely inducible in
PGRP-LA2A mutant tracheae indicating that PGRP-LA is not a
core member of the Imd pathway, but rather might participate in
the fine-tuning of the epithelial immune response. It could not be
fully excluded that our microarray results were caused by the
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Figure 4. PGRP-LA is not required for the systemic immune response. A,B. Survival analysis upon septic injury with Ecc15 in females (A) and
E. faecalis in males (B). Full results of log-rank tests corrected with Bonferroni’s method: in A, wt vs RelE20: **, wt vs LA2A: ns, wt vs LCE12: **, wt vs
LALCD: **, LCE12 vs LALCD:*; in B, wt vs Spzrm7:**, wt vs LA2A: ns, wt vs LALCD: ns. C–E. RT-qPCR analysis of Dpt (C, D) and Drs (E) expression in whole
females after septic injury with Ecc15 (C), L. monocytogenes (D), and M. luteus (E). F–H. RT-qPCR analysis of Dpt expression in whole females after oral
infection with P. entomophila (F) or Ecc15 (G), and in males 6 h after genital infection by Ecc15 (H). In G, H, data are shown as a ratio of LBD 16 h (G)
and wt (H). In C–G, data were analyzed by 2-way ANOVA with Bonferroni’s multiple comparison post-tests (in C, F, G, a and b groups are statistically
different in infected flies: *, *** and *** respectively. In D, wt vs RelE20 (24 h): **, wt vs LA2A: ns (Spzrm7 is not included in the tests). In F and G, no
significant differences were observed in unchallenged flies). In B, C, G, H, data are the mean of two repeats and error bars indicate data variation. In
A, D, E, data are the mean of three independent repeats and error bars indicate standard errors. In F, data are the mean of 8 repeats from two
independent experiments and error bars indicate standard errors. wt – wild type; LA2A – PGRP-LA2A; LCE12 – PGRP-LCE12; LALCD – PGRP-[LA, LC]D; RelE20 –
RelishE20; Spzrm7 – Spa¨tzlerm7. LBD – PGRP-LBD; LA2A, LBD (1) and (2) are two strains derived from independent recombination events between LA2A and
LBD; nd – no data; ns: non significantly different; *,**,*** show statistical differences with p,0.05, p,0.01 and p,0.001 respectively.
doi:10.1371/journal.pone.0069742.g004
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Figure 5. Microarray characterization of the tracheal immune response in wild-type larvae. A. Distribution of regulated genes, based on
their up or down-regulation and their fold change in the microarray. Black and white bar portions represent the genes whose expression is affected
or not affected in RelE20 respectively. B. Comparison of the distribution of genes up-regulated in the tracheae upon Ecc15 bacterial infection to that of
genes induced in the gut upon Ecc15 ingestion and in whole flies upon septic injury with Ecc15 [40,47]. * indicates that the gene expression is
affected in RelE20. The number of genes induced in each tissue is indicated in brackets. C. Repartition of induced (left) and repressed (right) genes in
defined categories of gene ontology.
doi:10.1371/journal.pone.0069742.g005
Characterization of PGRP-LA in Drosophila Immunity
PLOS ONE | www.plosone.org 7 July 2013 | Volume 8 | Issue 7 | e69742
Figure 6. PGRP-LA promotes epithelial antibacterial responses. A. List of the genes that are down-regulated (left) or up-regulated (right) in
the PGRP-LA2A mutant, with a fold change versus wild-type Canton S (Cs).3 in either unchallenged or infected conditions, in the microarray analysis.
For each gene the fold change in Ecc15-challenged versus unchallenged Cs larvae, the fold-change in PGRP-LA2A mutant versus Cs in unchallenged
condition (UC) and after Ecc15 infection, and the fold change in RelE20 versus Cs Ecc15-challenged larvae are provided. B. RT-qPCR analysis Def and Drs
expression in tracheae of unchallenged wild-type and LA2A larvae. C. Observation of Drs-GFP larvae 4 days after bacterial infection with Ecc15 at 18uC.
All the larvae observed here (including of PGRP-LA2A) were showing Drs-GFP signal in the tracheae in more than half of the larvae, classified as ++++ in
Figure S2. D. Drs-GFP signal coverage observed in unchallenged tracheae of wild-type, PGRP-LA2A, PGRP-LBD or PGRP-LA2A, LBD larvae. (2, +, ++, +++
classification is the same as in B, +/2 indicates a high background level of fluorescence compared to 2). Data were analyzed by grouping2 and +/2
on one side, +, ++ and +++ on the other side for statistical analysis. *** show statistical difference between the proportion of larvae with Drs-GFP
signal in PGRP-LA2A vs PGRP-LA2A, LBD strains. E–G. RT-qPCR quantification after Ecc15 infection of Def (E, F) and Dpt (G) expression in the larval
Characterization of PGRP-LA in Drosophila Immunity
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e69742
genetic background (1/8th of the genetic background was still
different in the wild-type and mutant strains) or by an indirect
influence of the microbiota that is known to influence epithelial
responses [49] and could differ between the two strains. Thus, we
repeated and extended experiments using additional strains and
conditions. We first monitored the level of Drosomycin-GFP in wild-
type and PGRP-LA2A tracheae of unchallenged and Ecc15-infected
larvae. After infection with Ecc15, we observed that the proportion
of Drosomycin-GFP expressing larvae was smaller in PGRP-LA2A
mutants (Figure S3) and that even when selecting larvae
expressing the reporter, the fluorescence intensity was lower in
PGRP-LA2A mutant than in wild-type tracheae (Figures S3, 6C).
The difference was less clear in unchallenged conditions, as the
expression of Drosomycin-GFP was very low, even in the wild-type
(Figure 6D). Thus, we decided to use a fly line deficient for
PGRP-LB, which encodes a negative regulator of the Imd pathway
[18]. As reported before, tracheae of larvae where PGRP-LB is
down-regulated express a much higher level of Drosomycin-GFP
reporter compared to wild-type [17]. We observed that the GFP
signal in double mutant PGRP-LA2A, LBD larvae was significantly
more restricted than in PGRP-LBD larvae (Figure 6D).
To confirm that the effect seen on the activation of the Imd
pathway was not due to the genetic background, we also
performed a genomic rescue of the PGRP-LA deficiency line with
a transgene containing the PGRP-LA locus including 4 kb
upstream of the start codon (referred to as [PGRP-LA]2M). In
both the tracheae and the midgut, the expression of PGRP-LA in
the rescue line (genotype: [PGRP-LA]2M; PGRP-LA2A) was similar
to wild-type levels (Figure S1B, C). In order to elude any effect of
the microbiota, we generated axenic (germ-free) PGRP-LA2A and
[PGRP-LA]2M; PGRP-LA2A lines, reconstituted a gnotobiotic
microbiota composed of Lactobacillus plantarum and Lactobacillus
brevis only, two bacteria commonly found in Drosophila microbiota
(reviewed in [50]) and maintained these germ-free and gnotobiotic
lines in autoclaved fly medium. In these conditions, the levels of
Drosomycin and Defensin in unchallenged tracheae were very low
and too variable, preventing us to analyze the effect of the PGRP-
LA2A deletion on basal Imd pathway activation by RT-qPCR. We
therefore focused our analysis on tracheae of larvae collected 24 h
after bacterial infection with Ecc15 at 29uC. Defensin and Drosomycin
expression was 3 to 10-fold lower in the tracheae of PGRP-LA2A
compared to [PGRP-LA]2M; PGRP-LA2A infected larvae
(Figures 6E, S4). The effect of PGRP-LA on tracheal antimicro-
bial genes upon Ecc15 infection was still observed when larvae
were raised in germ-free conditions. The results were however
variable and statistical significance could only be observed when
monitoring Defensin after infecting germ-free larvae (Figures 6E).
To extend our analysis, we next investigated whether PGRP-LA
was involved in the Imd pathway activation in the gut of adults
since PGRP-LA is also enriched in this tissue (Figure 2A).
Figure 6F shows that the level of Defensin was significantly lower
in the hindgut of PGRP-LA2A flies as compared to wild-type
following oral infection with Ecc15. The effect of PGRP-LA on
Defensin expression was less marked in the midgut. To confirm this
result, we also monitored Diptericin expression in the gut of PGRP-
LA2A and [PGRP-LA]2M; PGRP-LA2A adult flies raised in either
germ-free or gnotobiotic conditions, and then infected with Ecc15.
Figure 6G shows that Diptericin expression was also lower in the
gut of PGRP-LA2A mutant compared to [PGRP-LA]2M; PGRP-
LA2A adults 20 h after oral infection with Ecc15 although this effect
was only significant when infecting previously germ-free flies
(Figure 6G).
Together with the microarray analysis, these data suggest that
PGRP-LA positively regulates the Imd pathway in barrier
epithelia such as the tracheae and the gut.
Discussion
In this manuscript, we present a first detailed analysis of PGRP-
LA function. Our structural study predicts that the PGRP domain
of PGRP-LA is unlikely to bind peptidoglycan by itself. We next
show that over-expression of PGRP-LAD isoform, but not of PGRP-
LAC and PGRP-LAF, leads to the activation of Diptericin expression
in absence of infection. Our experiments placed PGRP-LAD
upstream of the Dredd caspase and of the Tak1 MAP3K. The
intracellular domain of PGRP-LAD contains a RHIM motif
similar to that observed in PGRP-LC and PGRP-LE for which it is
essential for Imd pathway activation [26]. This suggests that the
RHIM motif confers to PGRP-LAD the capacity to induce the
Imd pathway. Studies involving short mutations in PGRP-LC and
PGRP-LE reported that their RHIM motifs are not involved in
any physical interaction with Imd, the downstream adaptor of the
Imd pathway, but bind with Pirk, a negative regulator of the Imd
pathway [26,51]. Further analysis will be required to test whether
the different PGRP-LA isoforms physically interacts with Pirk
and/or with PGRP-LC. Collectively, this initial molecular
characterization of PGRP-LA suggests a modulatory role of this
PGRP in the Imd pathway.
Using a PGRP-LA-deficient line, we showed that PGRP-LA is not
required for the systemic production of antimicrobial peptides in
the adult. Consistent with this observation, mutations in PGRP-LA
did not increase the susceptibility to systemic bacterial infection.
This matches with the very low expression of PGRP-LA in the fat
body. Of note, phagocytosis was also not affected in the PGRP-
LA2A mutant (Figure S5). Consistently, previous studies on S2-
cells did not reveal any role of PGRP-LA in the induction of
antimicrobial peptides by peptidoglycan or Gram-negative bacte-
ria [23,24] or in the phagocytosis of Gram-negative or Gram-
positive bacteria [24]. All these data clearly indicate that PGRP-
LA is not compulsory for the systemic activation of the Imd or Toll
pathways, although a more specific role under a very specific
condition or in response to a specific form of peptidoglycan could
formally not be excluded.
Several studies have shown that the antimicrobial response of
Drosophila exhibits major differences depending on the tissue
[1,40,45,52,53]. Notably, regulatory mechanisms controlling the
antimicrobial response in barrier epithelia significantly differ from
that involved in fat body-mediated systemic immune response. For
instance, the expression of antimicrobial peptide genes (including
Drosomycin) in the midgut or the tracheae relies only on the Imd
tracheae (E) and in the female gut (F, G). In E and G, LA2A and [PGRP-LA]2M;LA2A lines were raised in germ-free conditions (GF) or gnotobiotic
conditions (LpLb) where the flora is composed of L. plantarum and L. brevis. Samples were dissected 20 h after Ecc15 infection. In F, wild-type and
LA2A flies were conventionally reared. In G, it should be noted that the level of Diptericin was 70% higher in infected midguts of conventionally-reared
[PGRP-LA]2M; PGRP-LA2A infected flies compared to wild-type, indicating differences in genetic background and/or microbiota between the two wild-
type strains. RT-qPCR data are calibrated to unchallenged wild-type in B, F and LA2A in E, G and statistical analysis is performed prior to calibration.
In B, data show the mean of 17 (Def) and 5 (Drs) independent experiments and error bars indicate standard errors. C shows data of one experiment
representative of 3 independent experiments. In D–G, data are the mean of at least three independent experiments and error bars indicate standard
error. Data analysis was performed by Mann-Whitney tests (B, E, G) and two-way ANOVA with Bonferroni’s post-tests (D, F).
doi:10.1371/journal.pone.0069742.g006
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pathway [45]. In addition, it has recently been shown that PGRP-
LE has a significant role in Imd pathway activation in the midgut
while PGRP-LC is the main sensor of Gram-negative bacteria
during systemic infection [27,28]. These differences are probably a
consequence of the necessity to maintain tight control on immune
activation according to the level of exposure to bacteria or
microbial products; while the hemocoel surrounding the fat body
remains sterile, organs such as the digestive tract and tracheae are
constantly in direct contact with the external environment. This
raises the possibility that PGRP-LA has a subtler role in barrier
epithelia where its expression is enriched. In support of this notion,
our microarray analysis revealed a lower expression of antimicro-
bial peptides in PGRP-LA2A tracheae of both Ecc15-infected and
unchallenged larvae. The idea that PGRP-LA could establish the
basal level of Imd pathway in unchallenged conditions is
intriguing. These results were confirmed in RT-qPCR
(Figure 6B), but limitations due to the low and variable levels
of antimicrobial gene expression in the tracheae and the gut in
unchallenged conditions, when maintaining fly lines in autoclaved
fly medium, did not allow us to confirm this hypothesis (data not
shown). Nevertheless, we observed that the expression of several
antimicrobial peptide genes was reduced in larval tracheae and
adult guts of PGRP-LA2A mutants upon Ecc15 infection. A rescue
experiment confirms that the phenotype is specifically linked to the
PGRP-LA deletion and not to the genetic background. However, in
normal laboratory conditions the PGRP-LA phenotype is not very
strong and we were unable to detect any infectious condition for
which a contribution of PGRP-LA to adult survival was
discernable.
Our results support the notion that PGRP-LA positively
regulates the antibacterial response in infected epithelia. However,
we cannot exclude subtle additional roles for PGRP-LA, such as its
participation in inter-organ communication by spreading immune
signaling from epithelia to another tissue (e.g. between the gut and
the tracheae). Such immune communication between tissues
occurs between several epithelia and the fat body in Drosophila
[17,44,46,54]. However, no role of PGRP-LA could be discerned
in the activation of the systemic response upon gut or genital
infections (Figure 4F–H).
The implication of several pattern-recognition receptors in the
gut highlights the complexity of mechanisms underlying bacterial
sensing in barrier epithelia. The conservation of PGRP-LA in
mosquito (contrary to PGRP-LE or PGRP-LF) where it is also
located in cluster with PGRP-LC suggests the conservation of its
function in other insect species. The genomic organization of the
PGRP-LA, LC, LF cluster is intriguing since the Imd-receptor
gene PGRP-LC is flanked by both a positive (PGRP-LA) and a
negative (PGRP-LF) regulator of the pathway. Future studies
should elucidate the mechanisms by which PGRP-LA modulates
the Imd pathway, notably to determine which PGRP-LA isoforms
are involved. Another question to address will be the respective
contributions of PGRP-LA, LC, and LE in the sensing of bacteria
in the intestine. Thus, our data add a layer of complexity to the
mechanism regulating the Imd pathway and further investigation
is needed to fully characterize the role of PGRP-LA.
The Drosophila tracheal immune response remained poorly
characterized [41,55,56]. In this study, we also present a general
analysis of tracheal transcriptome variations after bacterial
infection in larvae. Our data reveal a major role of the Imd
pathway, which controls the expression of half of the genes
regulated upon infection and of most of the immunity-related
genes, such as antimicrobial genes. This is in accordance with
previous reports showing that this pathway controls the local
production of antimicrobial peptide genes, in tracheae and the gut
[40,45,57]. We note that it also regulates genes involved in other
cellular functions such as metabolism. Interestingly, we observed
that many genes encoding putative or characterized cuticle
proteins are down-regulated upon infection. The shape of the
tracheae is maintained by helicoidal thickenings of the intima
called taenidiae [48]. Therefore, the down-regulation of structural
genes highlighted in our microarray suggests a remodeling of this
structure upon infection. Consistent with this down-regulation, an
apical-basal enlargement of the cells of the airway epithelium has
been previously reported in regions of the tracheae exhibiting a
strong immune response [41]. This enlargement might be
explained by a thinning of the cuticle and consequent loss of
rigidity. Thus, infection with Ecc15 not only induces an immune
and stress response, but also alters the metabolism and physiology
of tracheae. Interestingly, microarray comparison of the immune
response during systemic (fat body), gut, and tracheal immune
response reveals that only a small group of common genes are
induced, all regulated by the Imd pathway and encoding mainly
antimicrobial peptides and other pathway components. These
genes may therefore represent the ‘‘core’’ of Imd pathway that are
complemented by tissue-specific genes to achieve an optimal
immune response.
Materials and Methods
Fly Stocks
OregonR flies were used as wild-type controls for the PGRP-LA2A
original strain (Figure 4A, H, 6H, S2B), and CantonS flies were
used as wild-type controls of PGRP-LA2A introgressed into the
CantonS background (all other figures). Over-expression experi-
ments were controlled by crossing the da-Gal4 driver to w1118, the
strain in which the UAS construct insertions were generated.
RelishE20 (e+, RelE20), DreddB118, Tak11, PGRP-LCE12 and Spa¨tzlerm7
are described elsewhere [22,58–61]. The da-Gal4 line expresses
Gal4 ubiquitously and constitutively. The UAS-PGRP-LAC (inser-
tion R1), UAS-PGRP-LAD (insertion R4) and UAS-PGRP-LAF
(insertion R2) lines were obtained as follows. A full-length cDNA
of each isoform of PGRP-LA (using the CG32042_cDNA gold
GH4960, GH18280 and GH10945, respectively, from DGRC)
was placed downstream of the UAS sequence using the pUASt
vector. F1 progeny young adults carrying both the UAS construct
and the Gal4 driver were transferred to 29uC for optimal efficiency
of the UAS/Gal4 system.
Stocks were reared at 25uC on media prepared as follows: per
liter of water, 58.8 g inactivated yeast (Biospringer SpringalineH
BA95/0), 58.8 grams maize flour (Westhove Farigel Maize H1),
7.5 g agar, 58 mL of 1:1 mix of grape and multi-fruit juice were
combined with water and boiled at 80uC for 30 min. When the
mixture had cooled to 65uC, 4.85 ml of 99% proprionic acid and
30 ml of a 10% solution of methyl paraban in 85% ethanol were
added. After cooling to room temperature, live yeast was added on
the surface of the media, except for germ-free and gnotobiotic flies,
which were reared on autoclaved media in glass tubes without the
addition of live yeast.
PGRP-LA2A mutant was obtained by imprecise excision of the
G14937 P-element (KAIST library) and PGRP-[LA,LC]D by FRT
mediated deletion of the region between the P-elements 1930 and
4396, following previously published methods [62]. [PGRP-LA]2M
rescue line was generated using gap-repair and recombineering,
and final rescue construct carried by P[acman] vectors was
inserted into the PhiC31 landing site 51C on chromosome 2
(BDSC strain 24482) [63],[64]. Vector with PGRP-LA contain the
PGRP-LA gene including the following sequence (based on Flybase
release r5.47): 3L: 9323736–9331619.
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Drosophila stocks and crosses were maintained at 25uC in yeasted
tubes containing corn-meal fly medium. Germ-free lines were
generated by egg bleaching and kept in autoclaved fly medium.
Gnotobiotic lines were generated by introducing cultured L.
plantarum and L. brevis previously isolated from our fly lines into the
medium of germ-free lines and were also kept in autoclaved fly
medium.
Bacterial and fungal stocks
All bacteria were stored as frozen stocks (15% DMSO). Erwinia
carotovora carotovora 15 (Ecc15), Escherichia coli, Enterococcus faecalis,
Pseudomonas entomophila, and Micrococcus luteus were described
previously [61]. They were cultured on LB-Agar plates and grown
overnight in LB-medium at 29uC and generally used as pellets of
OD600 = 200, i.e. the OD600 of a 1/1000
th dilution of the pellet in
PBS was 0.2 corresponding to 4.1011 CFU.mL21 (exceptions are
mentioned below). Salmonella typhimurium, Listeria monocytogenes and
Candida albicans were described previously [61]. They were grown
overnight at 37uC, respectively in LB-medium, BHI, and YPG.
Aspergillus glaucus was kept as a spore-suspension at 4uC and
injected as such into the flies. While testing the susceptibility to
septic injury Ecc15 was tested at OD600 200 and 50, Salmonella
typhimurium at OD600 0.65 and 10
25, L. monocytogenes at OD600 0.65
and 1025, Enterococcus faecalis at OD600 5, 10, 15.
Infection and survival experiments
Septic injuries were made by pricking adults in the thorax with a
thin needle dipped into a concentrated bacterial pellet. Genital
infections were performed by touching the tip of the abdomen
with a 200 mL pipette-tip containing 10 mL of bacterial pellet [44].
For gut infection, flies were starved for 2 h, then allowed to feed
on a 1:1 mixture of 5% sucrose and concentrated bacteria
(OD600 = 200), peptidoglycan (5 mg/ml), or TCT (tracheal
cytotoxin; 0.046 mM) applied to a filter disk completely covering
the surface of standard fly medium. Flies were maintained at 29uC
and guts were dissected 16–24 h after contact with infected food.
In Figures 6F, S1, midgut was defined as the section of the gut
between the proventriculus (included) and the pylorus (midgut/
hindgut junction), while hindgut corresponds to the section
between the pylorus and the anus. Malpighian tubules were
excluded from both midgut and hindgut samples. In Figure 6G,
whole guts include the section between the crop (included) and the
anus, malpighian tubules being removed. A minimum of 20 flies
were used for survival experiments. Survival was scored once to
twice a day [61] and data were analyzed by logrank tests corrected
with Bonferroni’s method.
To monitor the immune response in the tracheae, two different
methods of infection were used. Method 1 (Microarray, Figures 5,
6A, C, D, S3): adults were allowed to lay eggs for 3 days then
removed, and 500 mL Ecc15 pellet (OD600 = 200) were added on
the 4th day into 28.5 mm-wide vials where larvae were developing.
The vials were then put at 18uC for 24 h and non-wandering 3rd-
instar larvae (with hand-shaped anterior spiracles) were dissected.
Method 2 (Figure 6E and S4): larvae were incubated for 30 min
in a 2-mL tube with a 1:1 mixture of mashed banana and Ecc15
(OD600 = 200), then the tube content was transferred in a fresh fly
vial and kept at 29uC [61].
RT-qPCR
Antimicrobial peptide genes and RpL32 mRNA quantification
by RT-qPCR was performed as described previously [61]. For
PGRP-LA, the primers were designed to amplify a region included
in all isoforms and in the deleted part of PGRP-LA2A to allow both
expression quantification and deletion control (sequences of the
qPCR primers: Fp: CCT-TTA-TGG-GCG-ACT-ATG-GC and
Rg: CTT-GGC-GTC-CCA-CGA-TTC) (Figure 1A). Unless
otherwise noted, all expression data are given as a ratio of the
expression level of the invariant mRNA RpL32. Each experiment
was performed with approximately 20 flies for each genotype.
Microarray Analysis
Larvae were infected with method 1 and dissected by gently
pulling the posterior spiracles backwards until the whole tracheae
went out. If needed, the anterior part of the tracheae was pulled
out in a second similar step. RNA pools from the tracheae
(including anterior spiracles) of 50 3rd instar larvae were isolated,
purified with RNA clean-up purification kits (Macherey Nagel),
and DNase treated. The samples were controlled for fat body
contamination by RT-qPCR on Fat body protein P6 (Fbp2). RNA
quality was controlled on Agilent 2100 Bioanalyzer chips. As the
quality of some samples was not good enough after this first
purification, RNA of all samples was ethanol precipitated to pass
Bioanalyzer quality control. For each sample, 100 ng of total RNA
was amplified and labeled using the GeneChip IVT Labeling Kit
according to the protocol provided by the supplier. Affymetrix
Drosophila Genome 2.0 arrays were hybridized with 30 mg of
labeled cRNA, washed, stained, and scanned according to the
protocol described in the Affymetrix Manual. Three independent
repeats were performed for each condition and gene expression
profiles from challenged larvae were normalized to their controls.
Statistical analyses were performed using the R and Bioconductor
statistical packages. Full dataset can be found at http://
lemaitrelab.epfl.ch/ and has been deposited at EMBL-EBI
database (Accession number: E-MEXP-3925).
Imaging
For GFP observation, flies were dissected in PBS and either
directly observed under a Leica MZ16F dissecting microscope, or
mounted in PBS for imaging with a Zeiss Axioimager Z1. Images
were captured with a Leica DFC300FX camera and Leica
Application Suite or with an Axiocam MRn camera and
Axiovision respectively.
Phagocytosis assay
The phagocytosis assay was performed as previously published
[65]. Briefly, 41.1 nL of S. aureus or E. coli bioparticles
(20 mg.mL21) were injected in the fly abdomen. Flies were left
for 30–40 min at 25uC and injected with 6669 nL of 0.4% trypan
blue.
Accession Numbers
The Flybase (www.flybase.org) accession numbers for genes
mentioned in the microarray are indicated in the data (Figure 6A,
Table S1). The accession numbers for genes mentioned in the rest
of this study are: Defensin (CG1385), Diptericin (CG12763), Drosocin
(CG10816), Drosomycin (CG10816), PGRP-LA (CG32042), PGRP-
LB (CG14704), PGRP-LC (CG4432), PGRP-LF (CG4437), da
(daughterless, CG5102), pirk (CG15678) and Relish (CG11992). The
vectorbase (www.vectorbase.org) accession numbers for Culex and
Anopheles homologs of PGRP-LA are CPIJ006558 and
AGAP005205 respectively.
Supporting Information
Table S1 Expression profile of the genes regulated in
the tracheae upon bacterial infection in larvae. List of the
genes showing a fold change .2, upon Ecc15 infection, in the
tracheae of CantonS larvae. Fold changes in CantonS and RelE20 are
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indicated. In the ‘‘Rel’’ column, ‘‘R’’ indicates the genes whose
regulation is affected in RelE20 mutant. The columns ‘‘sys’’, ‘‘gut’’
and ‘‘sys+gut’’ show respectively the genes regulated in whole flies
upon septic injury with Ecc15 [47], in the gut upon Ecc15 ingestion
[40], and in both conditions; for each tissue,‘‘+’’ means that the
gene is up-regulated ‘‘2’’ that it is repressed. AvgExp: mean signal
over all chips.
(PDF)
Figure S1 PGRP-LA expression in tissues. RT-qPCR
analysis of PGRP-LA expression in wild-type adult female tissues
(A) and in adult female midguts (B) and larval tracheae (C) of wild-
type and [PGRP-LA]2M; PGRP-LA2A strains. Data are normalized
to RpL32 and shown as a ratio of the expression in the wild-type.
In A, a single experiment was performed. In B, data are the mean
of three independent experiments, error bars indicate standard
errors and data were analyzed by 2-way ANOVA with Bonferroni
post-tests. In C, data are the mean of two independent
experiments and error bars indicate data variation.
(TIF)
Figure S2 PGRP-LA is not required for the systemic
immune response. A–C. Survival analysis of flies after injection
with S. typhimurium (A, OD 1025, 69 nL injected), L. monocytogenes
(B, OD 6.5, 9.2 nL injected), A. glaucus (C, spore suspension, 69 nL
injected). D,E. Dpt expression after injection of 9.2 nL of
monomeric (tracheal cytotoxin, TCT, 0.46 mM) or polymeric
peptidoglycan (PGN, 5 mg.mL21) (A) and after septic injury with
Ecc15 in larvae (B).
(TIF)
Figure S3 Tracheal Drs response in wt and PGRP-LA2A
deficient larvae (GFP). Fluorescence observed in the tracheae
of wild-type and PGRP-LA2A larvae expressing the Drs-GFP
reporter gene 4 days after bacterial infection with Ecc15 at
18uC. (2) no fluorescence (+) fluorescence in the spiracles only,
(++) in the tracheal trunks, (+++) in the tracheae in less than half of
the larva or (++++) in the tracheae in more than half of the larva. N,
NN, NNN: increasing intensity of fluorescence. Data of one experiment
representative of 3 independent experiments are shown.
(TIF)
Figure S4 Tracheal Drs response in wt and PGRP-LA2A
deficient larvae (RT-qPCR). RT-qPCR quantification of Drs
expression in the larval tracheae 24 h after Ecc15 infection in LA2A
and [PGRP-LA]2M;LA2A lines raised in germ-free conditions or
gnotobiotic conditions (LpLb) where the flora is composed of L.
plantarum and L. brevis. Data show the mean of 4 repeats and error
bars indicate standard errors. Data were analyzed by Mann-
Whitney tests, differences are non significant.
(TIF)
Figure S5 PGRP-LA is not required for the phagocyto-
sis. Fluorescent images of fly abdomens after injection of S. aureus
or E. coli nanoparticles. Data show representative results of one
experiment.
(TIF)
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